Latest Insider Transactions at Myomo, Inc. (MYO)
This section provides a real-time view of insider transactions for Myomo, Inc. (MYO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MYOMO, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MYOMO, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,700
-5.14%
|
$20,100
$3.76 P/Share
|
|
Sep 04
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
139
-0.11%
|
$417
$3.89 P/Share
|
|
Sep 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,029
-1.53%
|
$8,116
$4.01 P/Share
|
|
Aug 05
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.1%
|
$384
$3.96 P/Share
|
|
Jul 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.09%
|
$242
$2.85 P/Share
|
|
Jul 01
2024
|
Micah Mitchell Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,500
-7.77%
|
$46,500
$3.02 P/Share
|
|
Jul 01
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,868
-8.84%
|
$38,604
$3.02 P/Share
|
|
Jul 01
2024
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,436
-6.3%
|
$76,308
$3.02 P/Share
|
|
Jun 10
2024
|
Micah Mitchell Chief Commercial Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
6,837
+3.31%
|
$20,511
$3.38 P/Share
|
|
Jun 10
2024
|
Harry Kovelman Chief Medical Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
5,347
+3.54%
|
$16,041
$3.38 P/Share
|
|
Jun 10
2024
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,620
-2.56%
|
$31,860
$3.38 P/Share
|
|
Jun 05
2024
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+19.5%
|
-
|
|
Jun 05
2024
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+14.45%
|
-
|
|
Jun 05
2024
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+25.99%
|
-
|
|
Jun 05
2024
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+11.93%
|
-
|
|
Jun 05
2024
|
Thomas F Kirk |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+4.62%
|
-
|
|
Jun 05
2024
|
Thomas Aloysius Crowley Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+22.26%
|
-
|
|
Jun 05
2024
|
Milton Mayo Morris |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+9.48%
|
-
|
|
Jun 05
2024
|
Heather C Getz |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+50.0%
|
-
|
|
Jun 05
2024
|
Amy K. Knapp |
BUY
Grant, award, or other acquisition
|
Direct |
12,034
+11.61%
|
-
|
|
Jun 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.12%
|
$363
$3.48 P/Share
|
|
May 29
2024
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
50,000
+17.45%
|
$150,000
$3.5 P/Share
|
|
May 15
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
35,426
-26.55%
|
$106,278
$3.69 P/Share
|
|
May 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.11%
|
$438
$3.84 P/Share
|
|
Apr 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.11%
|
$292
$2.97 P/Share
|
|
Mar 14
2024
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
50,000
+21.14%
|
$150,000
$3.5 P/Share
|
|
Mar 11
2024
|
Micah Mitchell Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,359
-3.31%
|
$16,077
$3.51 P/Share
|
|
Mar 11
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,590
-4.7%
|
$19,770
$3.51 P/Share
|
|
Mar 11
2024
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,774
-2.21%
|
$23,322
$3.51 P/Share
|
|
Mar 05
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
147
-0.1%
|
$441
$3.88 P/Share
|
|
Feb 05
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
146
-0.1%
|
$438
$3.21 P/Share
|
|
Jan 19
2024
|
Milton Mayo Morris |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+19.54%
|
$75,000
$3.8 P/Share
|
|
Jan 03
2024
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
145
-0.1%
|
$580
$4.69 P/Share
|
|
Dec 08
2023
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
14,997
-33.33%
|
-
|
|
Dec 05
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-0.07%
|
$396
$4.02 P/Share
|
|
Dec 01
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,333
-5.59%
|
-
|
|
Nov 28
2023
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
14,997
-25.0%
|
-
|
|
Nov 20
2023
|
Thomas F Kirk |
BUY
Open market or private purchase
|
Direct |
50,000
+26.81%
|
$150,000
$3.1 P/Share
|
|
Nov 06
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-0.08%
|
$121
$1.41 P/Share
|
|
Oct 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
123
-0.08%
|
$123
$1.1 P/Share
|
|
Sep 08
2023
|
Milton Mayo Morris |
BUY
Open market or private purchase
|
Direct |
15,000
+16.14%
|
$15,000
$1.06 P/Share
|
|
Sep 05
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-0.08%
|
$0
$0.87 P/Share
|
|
Aug 30
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
48,400
+5.22%
|
$0
$0.74 P/Share
|
|
Aug 29
2023
|
Harry Kovelman Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
8,333
+5.28%
|
$0
$0.6 P/Share
|
|
Aug 29
2023
|
David A Henry Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
41,666
+10.58%
|
$0
$0.6 P/Share
|
|
Aug 29
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
37,000
+4.27%
|
$0
$0.78 P/Share
|
|
Aug 28
2023
|
Paul R Gudonis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
42,500
+5.09%
|
$0
$0.75 P/Share
|
|
Aug 03
2023
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-0.09%
|
$0
$0.71 P/Share
|
|
Jul 05
2023
|
Harry Kovelman Chief Medical Officer |
BUY
Payment of exercise price or tax liability
|
Direct |
109
+0.08%
|
$0
$0.6 P/Share
|
|
Jun 28
2023
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+36.12%
|
-
|